Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Angiodynamics Inc (NQ: ANGO ) 7.130 -0.050 (-0.70%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 22, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Angiodynamics Inc < Previous 1 2 3 4 5 6 7 Next > Nasdaq Edges Lower; Morgan Stanley Earnings Top Views July 16, 2024 Via Benzinga Medical Devices Maker AngioDynamics Lays Out Growth Plans, Issues Upbeat Annual Guidance July 16, 2024 AngioDynamics reported a Q4 2024 adjusted EPS loss of $(0.05), beating the consensus of $(0.16). Sales rose 1.9% to $79.1 million, driven by strong performance in the Med Tech segment. The company... Via Benzinga Why Charles Schwab Shares Are Trading Lower By Over 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session July 16, 2024 Via Benzinga Crude Oil Down 1%; Bank of America Posts Upbeat Earnings July 16, 2024 Via Benzinga Exposures Fossil Fuels UnitedHealth Posts Better-Than-Expected Earnings, Joins AngioDynamics, Bank of America And Other Big Stocks Moving Higher On Tuesday July 16, 2024 Via Benzinga ANGO Stock Earnings: AngioDynamics Beats EPS, Beats Revenue for Q4 2024 July 16, 2024 ANGO stock results show that AngioDynamics beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2024. Via InvestorPlace AngioDynamics Reports Fiscal Year 2024 Fourth Quarter and Full-Year Financial Results July 16, 2024 From AngioDynamics, Inc. Via Business Wire AngioDynamics to Report Fiscal 2024 Fourth Quarter and Full-Year Financial Results on July 16, 2024 July 08, 2024 From AngioDynamics, Inc. Via Business Wire AngioDynamics Announces CE Mark Approval in Europe for AlphaVac F18⁸⁵ System May 21, 2024 From AngioDynamics, Inc. Via Business Wire AngioDynamics’ APEX-AV Trial Results Assessing AlphaVac F18⁸⁵ System in Treatment of Pulmonary Embolism Presented at SCAI 2024 Scientific Sessions May 06, 2024 From AngioDynamics, Inc. Via Business Wire Insiders Buying Zumiez And 3 Other Stocks April 09, 2024 Although U.S. stocks closed little changed on Monday, there were a few notable insider trades. Via Benzinga Medical Devices Focused AngioDynamics Unveils Upbeat 2024 Financial Outlook, Stock Soars April 04, 2024 FDA grants 510(k) clearance to AngioDynamics' AlphaVac F1885 System for pulmonary embolism. Expanded indication broadens treatment options. Sales slightly below consensus, but pro forma basis sees... Via Benzinga Exposures Product Safety ANGO Stock Earnings: AngioDynamics Misses EPS, Misses Revenue for Q3 2024 April 04, 2024 ANGO stock results show that AngioDynamics missed analyst estimates for earnings per share and missed on revenue for the third quarter of 2024. Via InvestorPlace Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday April 04, 2024 We're diving into the biggest pre-market stock movers that traders are going to want to keep an eye on for Thursday morning! Via InvestorPlace AngioDynamics Reports Fiscal Year 2024 Third Quarter Financial Results; Updates Fiscal Year 2024 Guidance to Reflect Asset Divestiture April 04, 2024 From AngioDynamics, Inc. Via Business Wire AngioDynamics Receives 510(k) Clearance for AlphaVac F1885 System in Treatment of PE April 04, 2024 From AngioDynamics, Inc. Via Business Wire Earnings Scheduled For April 4, 2024 April 04, 2024 Companies Reporting Before The Bell • Conagra Brands (NYSE:CAG) is likely to report quarterly earnings at $0.65 per share on revenue of $3.01 billion. Via Benzinga AngioDynamics Resolves Decade-Long Patent Litigation With Becton, Dickinson In Settlement Agreement April 02, 2024 AngioDynamics resolves decade-long patent litigation with Becton, Dickinson in landmark settlement, streamlining legal expenses and marking a significant milestone for the company. Via Benzinga Topics Intellectual Property Exposures Intellectual Property AngioDynamics Announces Settlement of All Patent Litigation with C.R. Bard, Inc. April 01, 2024 From AngioDynamics, Inc. Via Business Wire AngioDynamics to Report Fiscal 2024 Third Quarter Financial Results on April 4, 2024 March 19, 2024 From AngioDynamics, Inc. Via Business Wire AngioDynamics to Participate in a Fireside Chat at the Oppenheimer Virtual Healthcare MedTech & Services Conference March 06, 2024 From AngioDynamics, Inc. Via Business Wire Hidden Gems: 7 Oversold Stocks Ready for a Major Rebound March 04, 2024 While red ink signals danger, for these oversold stocks ready for rebound, they could imply upside opportunities. Via InvestorPlace AngioDynamics Announces Sale of PICC and Midline Product Portfolios to Spectrum Vascular for $45 Million February 15, 2024 From AngioDynamics, Inc. Via Business Wire AngioDynamics (ANGO) Stock Sinks As Market Gains: Here's Why February 11, 2024 The medical device maker's shares have seen an increase of 1.49% over the last month, not keeping up with the Medical sector's gain of 2.05% and the S&P 500's gain of 5.07%. Via Talk Markets Topics Stocks Exposures US Equities AngioDynamics Announces FDA 510(k) Clearance of Auryon XL Radial Access Catheter to Treat Peripheral Arterial Disease January 23, 2024 From AngioDynamics, Inc. Via Business Wire Raymond James Maintains Outperform Rating for AngioDynamics: Here's What You Need To Know January 09, 2024 Via Benzinga Robinhood To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Monday January 08, 2024 Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Via Benzinga Why AngioDynamics Stock Got Destroyed Today January 05, 2024 The medical technology company is a perennial underperformer, but its latest quarterly report was worse than expected. Via The Motley Fool Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session January 05, 2024 Shares of Applied Therapeutics, Inc. Via Benzinga ANGO Stock Earnings: AngioDynamics Beats EPS, Misses Revenue for Q2 2024 January 05, 2024 ANGO stock results show that AngioDynamics beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. Via InvestorPlace < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.